SCHEMBL821940

SCHEMBL821940

CC(O)COC(=O)C(O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.50
MAPK1 P28482 1/20 0.50
HPGD P15428 1/20 0.46
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
CYP2D6 P10635 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CYP1A2 P05177 1/20 0.44
PKM P14618 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KMT2A Q03164 2/20 0.44
CHRM2 P08172 5/20 0.44
CHRM1 P11229 5/20 0.44
CHRM3 P20309 4/20 0.44
CHRM4 P08173 3/20 0.44
ALDH1A1 P00352 3/20 0.43
CHRM5 P08912 1/20 0.43
BLM P54132 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28163281 0.89 ALDH1A1 (0.55) LMNAMAPK1HPGDCES2CES1
SCHEMBL20799232 0.89 ALDH1A1 (0.55) LMNAMAPK1HPGDCES2CES1
SCHEMBL28163280 0.89 ALDH1A1 (0.55) LMNAMAPK1HPGDCES2CES1
SCHEMBL23766622 0.82 MAPT (0.39) LMNAMAPK1CES2CES1HSD17B10
SCHEMBL27590464 0.81 MMP8 (0.57) LMNAMAPK1HPGDCES2CES1
SCHEMBL3266292 0.81 MMP8 (0.57) LMNAMAPK1HPGDCES2CES1
SCHEMBL279960 0.81 MMP8 (0.57) LMNAMAPK1HPGDCES2CES1
SCHEMBL4297584 0.81 MMP8 (0.57) LMNAMAPK1HPGDCES2CES1
SCHEMBL10787054 0.80 LMNA (0.58) LMNAMAPK1HPGDCES2CES1
SCHEMBL27721038 0.80 LMNA (0.48) LMNAMAPK1HPGDCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 LMNA 570/4885MAPK1 1917/4885HPGD 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.